Atlas Trials

A Clinical Study of BioTTT001 in Combination With SOX and Toripalimab in Patients With Gastric Cancer

Clinical trial NCT06283121 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06283121
Sponsor
China Medical University, China
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer, Metastatic
Start date
2024-04-02
Primary completion
2027-11-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.